Jarret Fass is the Founder and Managing Partner of Pierpoint Capital, a family office-backed platform that invests in and launches healthcare technology companies in the U.S. and Israel. As a passionate business builder, Jarret cofounded, capitalized and is an active board member of three clinical-stage medical technology companies: Hemodynamx (aortic stenosis), Nephronyx (heart failure) and Emanate Biomedical (oral health) of which he is serving as CEO. He also currently sits on the board of LeanTaas, CoreFlow, AdvaMed Accel and the Anushkaa Foundation. Previously, Jarret led the firm’s investment in and was responsible for corporate development for Hospital IQ (acquired by Bain Capital) and served on the board of global nonprofit MiracleFeet. He began his career as an Analyst in the Corporate Strategy Group at Bear Stearns and as a Principal at technology-focused private equity firm Selway Capital. Jarret holds a BA from Connecticut College and an MBA from Columbia Business School.

Email: jfass@pierpointcap.com